Drug
TRC101
TRC101 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
1
25%
Ph phase_3
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 33 (75.0%)
Trials by Status
terminated125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_3
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
NCT03710291
completedphase_3
Long-term Safety Extension to Study TRCA-301
NCT03390842
completedphase_3
Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
NCT03317444
completedphase_1
Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
NCT02809183
Clinical Trials (4)
Showing 4 of 4 trials
NCT03710291Phase 3
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
NCT03390842Phase 3
Long-term Safety Extension to Study TRCA-301
NCT03317444Phase 3
Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
NCT02809183Phase 1
Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4